Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection
Aug 20, 2026 - 00:11:37
Radio and PodcastLive Radio & PodcastsHealth
Advancing MOGAD Care
No Label: Michael Levy, MD, PhD No Label: Peter V. Sguigna, MD What do the latest METEOROID trial results mean for neurologists treating myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)? Michael Le...
About This Episode
Advancing MOGAD Care is an episode from NeuroFrontiers by ReachMD. No Label: Michael Levy, MD, PhD No Label: Peter V. Sguigna, MD What do the latest METEOROID trial results mean for neurologists treating myelin oligodendrocyte glycoprotein...
Podcast
This episode belongs to NeuroFrontiers.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jun 24, 2026, 00:10:04 long, audio available.
Related Episodes
Continue listening to more episodes from NeuroFrontiers.
Multidisciplinary Coordination in TK2d Diagnosis and Management
Jun 24, 2026 - 00:11:15
Navigating Stem Cell Therapy Conversations in MS
Jun 8, 2026 - 00:04:45
Cognitive Screening in MS: Practical Strategies and Modern Approaches
May 28, 2026 - 00:03:30
Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
May 14, 2026 - 00:14:45
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
May 14, 2026 - 00:13:30
Understanding Variability in Myasthenia Gravis
May 1, 2026 - 00:03:45